Abstract
BACKGROUND: A previously published failure-type specific risk model showed good performance in the original cohort.
AIM: to validate the model and separate patients with high- and low-risk loco-regional failure (LRF).
GOAL: to identify patients potentially suitable for treatment intensification trials.
METHODS: Validation data: 756 patients from two institutions (different countries). Predictive performance was evaluated by Brier scores and AUCs. Discriminatory performance was compared to Union for International Cancer Control (UICC) staging (versions 7 and 8).
RESULTS: The model's 3-year AUC for LRF was 65%, significantly better than UICC7 staging, but no significant difference to UICC8. Model-based risk stratification and UICC8 both identified high-risk patient groups with 3-year LRF ≈30%. The population mean was 18%.
CONCLUSIONS: The model performed well on a group level. UICC8 staging performed equally well. Although developed for the endpoint of OS, an improvement from UICC version 7 to version 8 was evident also for the prediction of LRF.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Head & Neck - Journal for the Sciences and Specialties of the Head and Neck |
Antal sider | 8 |
ISSN | 1043-3074 |
DOI | |
Status | E-pub ahead of print - 31 jan. 2025 |